B-cell stimulatory factor 1 activates resting B cells

Proc Natl Acad Sci U S A. 1985 May;82(9):2935-9. doi: 10.1073/pnas.82.9.2935.

Abstract

B-cell stimulatory factor 1 (BSF-1) is a T-cell-derived lymphokine that acts together with low concentrations of anti-IgM antibodies to stimulate resting B cells to enter the G1 phase of the cell cycle and to synthesize DNA. We show here that supernatants from EL-4 cells, rich in BSF-1 activity, and BSF-1 purified by high-pressure liquid chromatography (HPLC-BSF-1) act on resting B cells, in the absence of anti-IgM antibodies, to prepare them to respond to anti-IgM and BSF-1. A 24-hour preculture with BSF-1 speeds the entry into S phase of B cells subsequently cultured with anti-IgM and BSF-1 by approximately equal to 12 hours and causes substantial increase in cell volume of all resting B cells. Both of these effects, stimulated either by EL-4 supernatants or by HPLC-BSF-1, are inhibited by a monoclonal anti-BSF-1 antibody. These results lead us to propose that BSF-1 should be regarded as a B-cell activation factor.

MeSH terms

  • Animals
  • Antibodies, Anti-Idiotypic / immunology
  • B-Lymphocytes / cytology
  • B-Lymphocytes / immunology*
  • Female
  • Growth Substances / pharmacology*
  • Histocompatibility Antigens Class II / immunology
  • Immunoglobulin M / immunology
  • In Vitro Techniques
  • Interleukin-4
  • Interphase
  • Lymphocyte Activation*
  • Lymphokines / pharmacology*
  • Mice
  • Mice, Inbred BALB C

Substances

  • Antibodies, Anti-Idiotypic
  • Growth Substances
  • Histocompatibility Antigens Class II
  • Immunoglobulin M
  • Lymphokines
  • Interleukin-4